Deborah Crouch

Array ( [id] => 6685203 [patent_doc_number] => 20030121067 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-26 [patent_title] => 'V1a arginine vasopressin receptor disruptions, compositions and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/254088 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 30465 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 25 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20030121067.pdf [firstpage_image] =>[orig_patent_app_number] => 10254088 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6670632 [patent_doc_number] => 20030115617 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-19 [patent_title] => 'Thyrotropin releasing hormone receptor disruptions, compositions and methods relating thereto' [patent_app_type] => new [patent_app_number] => 10/253983 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 31652 [patent_no_of_claims] => 59 [patent_no_of_ind_claims] => 29 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20030115617.pdf [firstpage_image] =>[orig_patent_app_number] => 10253983 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6857866 [patent_doc_number] => 20030131367 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-10 [patent_title] => 'Kv3.3b potassium channel disruptions, compositions and methods related thereto' [patent_app_type] => new [patent_app_number] => 10/254008 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 29759 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 19 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0131/20030131367.pdf [firstpage_image] =>[orig_patent_app_number] => 10254008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6831615 [patent_doc_number] => 20030182673 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Calpain large subunit (n-CL4) cysteine protease gene disruptions, and compositions and methods related thereto' [patent_app_type] => new [patent_app_number] => 10/254074 [patent_app_country] => US [patent_app_date] => 2002-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23497 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 18 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20030182673.pdf [firstpage_image] =>[orig_patent_app_number] => 10254074 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6656040 [patent_doc_number] => 20030106081 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-06-05 [patent_title] => 'Unactivated oocytes as cytoplast recipients for nuclear transfer' [patent_app_type] => new [patent_app_number] => 10/234854 [patent_app_country] => US [patent_app_date] => 2002-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6860 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20030106081.pdf [firstpage_image] =>[orig_patent_app_number] => 10234854 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6740335 [patent_doc_number] => 20030157704 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-21 [patent_title] => 'Reagents and methods for identifying and modulating expression of genes regulated by CDK inhibitors' [patent_app_type] => new [patent_app_number] => 10/233032 [patent_app_country] => US [patent_app_date] => 2002-08-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 23980 [patent_no_of_claims] => 104 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20030157704.pdf [firstpage_image] =>[orig_patent_app_number] => 10233032 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6750456 [patent_doc_number] => 20030044976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'De-differentiation and re-differentiation of somatic cells and production of cells for cell therapies' [patent_app_type] => new [patent_app_number] => 10/228316 [patent_app_country] => US [patent_app_date] => 2002-08-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10538 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044976.pdf [firstpage_image] =>[orig_patent_app_number] => 10228316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674295 [patent_doc_number] => 20030059898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'Cells, vectors and methods for producing biologically active heterodimeric proteins' [patent_app_type] => new [patent_app_number] => 10/227274 [patent_app_country] => US [patent_app_date] => 2002-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 14585 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0059/20030059898.pdf [firstpage_image] =>[orig_patent_app_number] => 10227274 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7123990 [patent_doc_number] => 20050015819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-20 [patent_title] => 'Method of inducing the formation of neurofibrillary tangles in transgenic animals' [patent_app_type] => utility [patent_app_number] => 10/487546 [patent_app_country] => US [patent_app_date] => 2002-08-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7347 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0015/20050015819.pdf [firstpage_image] =>[orig_patent_app_number] => 10487546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7154230 [patent_doc_number] => 20050026220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Isolation and mobilization of stem cells expressing vegfr-1' [patent_app_type] => utility [patent_app_number] => 10/484511 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 11824 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20050026220.pdf [firstpage_image] =>[orig_patent_app_number] => 10484511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1031304 [patent_doc_number] => 06878858 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-04-12 [patent_title] => 'Rodent model for Parkinson\'s Disease' [patent_app_type] => utility [patent_app_number] => 10/216986 [patent_app_country] => US [patent_app_date] => 2002-08-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2758 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/878/06878858.pdf [firstpage_image] =>[orig_patent_app_number] => 10216986 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 609386 [patent_doc_number] => 07150989 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-12-19 [patent_title] => 'Telomerase immortalized neural progenitor cells' [patent_app_type] => utility [patent_app_number] => 10/217252 [patent_app_country] => US [patent_app_date] => 2002-08-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 12056 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/150/07150989.pdf [firstpage_image] =>[orig_patent_app_number] => 10217252 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6971778 [patent_doc_number] => 20050037488 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-17 [patent_title] => 'Alternative compositions and methods for the culture of stem cells' [patent_app_type] => utility [patent_app_number] => 10/486408 [patent_app_country] => US [patent_app_date] => 2002-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 23185 [patent_no_of_claims] => 66 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20050037488.pdf [firstpage_image] =>[orig_patent_app_number] => 10486408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346711 [patent_doc_number] => 20040192627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Mitochondrial genome replenishment' [patent_app_type] => new [patent_app_number] => 10/485407 [patent_app_country] => US [patent_app_date] => 2004-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8257 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192627.pdf [firstpage_image] =>[orig_patent_app_number] => 10485407 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6693908 [patent_doc_number] => 20030041340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'Animal model for fatty acid amide-related neurobehaviors' [patent_app_type] => new [patent_app_number] => 10/209002 [patent_app_country] => US [patent_app_date] => 2002-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 9037 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20030041340.pdf [firstpage_image] =>[orig_patent_app_number] => 10209002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6780182 [patent_doc_number] => 20030051264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Genetically modified cows having reduced susceptibility to mad cow disease' [patent_app_type] => new [patent_app_number] => 10/209194 [patent_app_country] => US [patent_app_date] => 2002-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19752 [patent_no_of_claims] => 80 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0051/20030051264.pdf [firstpage_image] =>[orig_patent_app_number] => 10209194 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6840014 [patent_doc_number] => 20030037354 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'Animal model with disrupted Fgf14 gene' [patent_app_type] => new [patent_app_number] => 10/206452 [patent_app_country] => US [patent_app_date] => 2002-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 16804 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0037/20030037354.pdf [firstpage_image] =>[orig_patent_app_number] => 10206452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6784652 [patent_doc_number] => 20030066100 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-03 [patent_title] => 'Capacitative calcium entry mechanism in porcine oocytes' [patent_app_type] => new [patent_app_number] => 10/192024 [patent_app_country] => US [patent_app_date] => 2002-07-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 6641 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0066/20030066100.pdf [firstpage_image] =>[orig_patent_app_number] => 10192024 [rel_patent_id] =>[rel_patent_doc_number] =>)